The detectable anti-interferon-γ autoantibodies in COVID-19 patients may be associated with disease severity

MLA

Po-Ku Chen, et al. “The Detectable Anti-Interferon-γ Autoantibodies in COVID-19 Patients May Be Associated with Disease Severity.” Virology Journal, vol. 20, no. 1, Feb. 2023, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s12985-023-01989-1.

APA

Po-Ku Chen, Kai-Jieh Yeo, Shih-Hsin Chang, Tsai-Ling Liao, Chia-Hui Chou, Joung-Liang Lan, Ching-Kun Chang, & Der-Yuan Chen. (2023). The detectable anti-interferon-γ autoantibodies in COVID-19 patients may be associated with disease severity. Virology Journal, 20(1), 1–11. https://doi.org/10.1186/s12985-023-01989-1

Chicago

Po-Ku Chen, Kai-Jieh Yeo, Shih-Hsin Chang, Tsai-Ling Liao, Chia-Hui Chou, Joung-Liang Lan, Ching-Kun Chang, and Der-Yuan Chen. 2023. “The Detectable Anti-Interferon-γ Autoantibodies in COVID-19 Patients May Be Associated with Disease Severity.” Virology Journal 20 (1): 1–11. doi:10.1186/s12985-023-01989-1.